These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24828469)

  • 21. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
    Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypomagnesemia: an evidence-based approach to clinical cases.
    Assadi F
    Iran J Kidney Dis; 2010 Jan; 4(1):13-9. PubMed ID: 20081299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
    Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
    Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease.
    Van Laecke S; Nagler EV; Verbeke F; Van Biesen W; Vanholder R
    Am J Med; 2013 Sep; 126(9):825-31. PubMed ID: 23891286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypomagnesemia in adolescents with eating disorders hospitalized for medical instability.
    Raj KS; Keane-Miller C; Golden NH
    Nutr Clin Pract; 2012 Oct; 27(5):689-94. PubMed ID: 22683565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes.
    Osorio JM; Bravo J; Pérez A; Ferreyra C; Osuna A
    Transplant Proc; 2010 Oct; 42(8):2910-3. PubMed ID: 20970568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
    Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
    Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation.
    June CH; Thompson CB; Kennedy MS; Nims J; Thomas ED
    Transplantation; 1985 Jun; 39(6):620-4. PubMed ID: 3890292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
    Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
    Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow transplant patients.
    June CH; Thompson CB; Kennedy MS; Loughran TP; Deeg HJ
    Transplantation; 1986 Jan; 41(1):47-51. PubMed ID: 3510494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubular and glomerular function in children after renal transplantation.
    Dagan A; Eisenstein B; Bar-Nathan N; Cleper R; Krause I; Smolkin V; Davidovits M
    Pediatr Transplant; 2005 Aug; 9(4):440-4. PubMed ID: 16048594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Serum Magnesium Level Associated With Serum Lipid Levels in Kidney Transplant Recipients?
    Goktepe B; Celtik A; Kivratma G; Sezer TO; Asci G; Toz H
    Transplant Proc; 2023 Jun; 55(5):1147-1151. PubMed ID: 37045703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating endothelial cells in pediatric renal transplant recipients.
    Gökceoğlu AU; Akman S; Köksoy S; Şahin E; Koyun M; Çomak E; Doğan Ç; Akbaş H; Dinçkan A
    Pediatr Nephrol; 2013 Dec; 28(12):2377-82. PubMed ID: 24018796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.
    Ledeganck KJ; Anné C; De Monie A; Meybosch S; Verpooten GA; Vinckx M; Van Hoeck K; Van Eyck A; De Winter BY; Trouet D
    Nutrients; 2018 May; 10(6):. PubMed ID: 29861470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.
    Van Ende C; Van Laecke S; Marechal C; Verbeke F; Kanaan N; Goffin E; Vanholder R; Jadoul M
    J Nephrol; 2014 Dec; 27(6):707-11. PubMed ID: 24816563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR; Lin CC; Lian JD
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia.
    Elisaf M; Panteli K; Theodorou J; Siamopoulos KC
    Magnes Res; 1997 Dec; 10(4):315-20. PubMed ID: 9513927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary angiotensinogen level is correlated with proteinuria in renal transplant recipients.
    Erdogmus S; Sengul S; Kocak S; Kurultak I; Celebi ZK; Kutlay S; Keven K; Erbay B; Erturk S
    Transplant Proc; 2013 Apr; 45(3):935-9. PubMed ID: 23622592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels.
    Stintzing S; Fischhaber D; Mook C; Modest DP; Giessen C; Schulz C; Haas M; Boeck S; Michl M; Stemmler J; Laubender RP; Heinemann V
    Anticancer Drugs; 2013 Oct; 24(9):969-74. PubMed ID: 23863616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of serum minerals changes after renal transplantation.
    Revúsová V; Zvara V; Borosová E; Pribylincová V; Reznícek J
    Czech Med; 1985; 8(4):214-20. PubMed ID: 3937710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.